ArticleExperimental & molecular medicine2025

Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer.

Dong Hoon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.